The Q-SEQ will use QMDx's nanowire biosensors arrayed in various different formations and structures to provide both short reads and long reads. The company says that Q-SEQ "is being developed to undertake 'genomic sequencing while you wait, because 'shotgun sequencing,'" as QMDx describes current next-generation sequencing methods, "cannot provide the full story of variation, as it is unable to resolve, copy number variations large repeats and rearrangements"—specifically, the structural variation that makes up a significant proportion of human genetic variation. According to QMDx, a combination of shotgun and targeted long read-length sequencing will facilitate the "definitive de-novo sequencing platform and deliver true whole-genome sequencing, not the approximately 70 -percent genome sequencing that shotgun platforms presently offer."